| Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma R Golfieri, E Giampalma, M Renzulli, R Cioni, I Bargellini, C Bartolozzi, ... British journal of cancer 111 (2), 255-264, 2014 | 598 | 2014 |
| Metroticket 2.0 model for analysis of competing risks of death after liver transplantation for hepatocellular carcinoma V Mazzaferro, C Sposito, J Zhou, AD Pinna, L De Carlis, J Fan, M Cescon, ... Gastroenterology 154 (1), 128-139, 2018 | 505 | 2018 |
| Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma A Cucchetti, F Piscaglia, M Cescon, A Colecchia, G Ercolani, L Bolondi, ... Journal of hepatology 59 (2), 300-307, 2013 | 428 | 2013 |
| Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection AWH Chan, J Zhong, S Berhane, H Toyoda, A Cucchetti, KQ Shi, T Tada, ... Journal of hepatology 69 (6), 1284-1293, 2018 | 390 | 2018 |
| Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver M Vivarelli, A Guglielmi, A Ruzzenente, A Cucchetti, R Bellusci, ... Annals of surgery 240 (1), 102-107, 2004 | 363 | 2004 |
| Impact of model for end‐stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis A Cucchetti, G Ercolani, M Vivarelli, M Cescon, M Ravaioli, G La Barba, ... Liver Transplantation 12 (6), 966-971, 2006 | 330 | 2006 |
| The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality TH Karlsen, N Sheron, S Zelber-Sagi, P Carrieri, G Dusheiko, E Bugianesi, ... The Lancet 399 (10319), 61-116, 2022 | 324 | 2022 |
| Can current preoperative imaging be used to detect microvascular invasion of hepatocellular carcinoma? M Renzulli, S Brocchi, A Cucchetti, F Mazzotti, C Mosconi, C Sportoletti, ... Radiology 279 (2), 432-442, 2016 | 313 | 2016 |
| Liver transplantation for “very early” intrahepatic cholangiocarcinoma: international retrospective study supporting a prospective assessment G Sapisochin, M Facciuto, L Rubbia‐Brandt, J Marti, N Mehta, FY Yao, ... Hepatology 64 (4), 1178-1188, 2016 | 297 | 2016 |
| Long-term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma⩽ 3 cm. Results of a multicenter Italian survey M Pompili, A Saviano, N De Matthaeis, A Cucchetti, F Ardito, B Federico, ... Journal of hepatology 59 (1), 89-97, 2013 | 290 | 2013 |
| Efficacy of selective transarterial chemoembolization in inducing tumor necrosis in small (< 5 cm) hepatocellular carcinomas R Golfieri, A Cappelli, A Cucchetti, F Piscaglia, M Carpenzano, E Peri, ... Hepatology 53 (5), 1580-1589, 2011 | 286 | 2011 |
| Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression M Vivarelli, A Cucchetti, F Piscaglia, G La Barba, L Bolondi, A Cavallari, ... Liver Transplantation 11 (5), 497-503, 2005 | 273 | 2005 |
| Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence M Vivarelli, A Cucchetti, G La Barba, M Ravaioli, M Del Gaudio, A Lauro, ... Annals of surgery 248 (5), 857-862, 2008 | 272 | 2008 |
| Is portal hypertension a contraindication to hepatic resection? A Cucchetti, G Ercolani, M Vivarelli, M Cescon, M Ravaioli, G Ramacciato, ... Annals of surgery 250 (6), 922-928, 2009 | 270 | 2009 |
| Clinical outcomes after endoscopic submucosal dissection for colorectal neoplasia: a systematic review and meta-analysis L Fuccio, C Hassan, T Ponchon, D Mandolesi, A Farioli, A Cucchetti, ... Gastrointestinal endoscopy 86 (1), 74-86. e17, 2017 | 240 | 2017 |
| Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population A Cucchetti, F Piscaglia, E Caturelli, L Benvegnù, M Vivarelli, G Ercolani, ... Annals of surgical oncology 16, 413-422, 2009 | 222 | 2009 |
| Low recurrence rate of hepatocellular carcinoma after liver transplantation: better patient selection or lower immunosuppression? M Vivarelli, R Bellusci, A Cucchetti, G Cavrini, N De Ruvo, AA Aden, ... Transplantation 74 (12), 1746-1751, 2002 | 213 | 2002 |
| The treatment of intermediate stage tumours beyond TACE: From surgery to systemic therapy PR Galle, F Tovoli, F Foerster, MA Wörns, A Cucchetti, L Bolondi Journal of hepatology 67 (1), 173-183, 2017 | 207 | 2017 |
| Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network: a pilot study A Cucchetti, F Piscaglia, ADE Grigioni, M Ravaioli, M Cescon, M Zanello, ... Journal of hepatology 52 (6), 880-888, 2010 | 196 | 2010 |
| Defining benchmarks in liver transplantation: a multicenter outcome analysis determining best achievable results X Muller, F Marcon, G Sapisochin, M Marquez, F Dondero, M Rayar, ... Annals of surgery 267 (3), 419-425, 2018 | 192 | 2018 |
Gian Luca GraziUniversity of FlorenceBestätigte E-Mail-Adresse bei unifi.it
